Why Hims & Hers Heath Shares Are Surging Today
Why Hims & Hers Heath Shares Are Surging Today
Hims & Hers Health Inc. (NYSE:HIMS) shares are moving higher on Monday after the company appointed former Novo Nordisk COO and President Kåre Schultz's to its Board of Directors.
Hims & Hers Hers Health Inc.（紐約證券交易所代碼：HIMS）週一股價走高，此前該公司任命了諾和諾德前首席運營官兼總裁卡雷·舒爾茨爲董事會成員。
Schultz brings extensive experience from his leadership roles at Novo Nordisk Inc. (NYSE:NVO), Teva Pharmaceutical Industries LTD (NYSE:TEVA) and Lundbeck.
舒爾茨曾在諾和諾德公司（紐約證券交易所代碼：NVO）、梯瓦製藥工業有限公司（紐約證券交易所代碼：TEVA）和靈北擔任領導職務，帶來了豐富的經驗。
At Novo Nordisk, Schultz was instrumental in establishing the company as a leader in diabetes care.
在諾和諾德，舒爾茨在使公司成爲糖尿病護理領域的領導者方面發揮了重要作用。
"Kåre's experience gives us an incredible wealth of expertise as we bring together the most valuable elements of clinical excellence, healthcare and technology to redefine health and wellness for our customers." said CEO Andrew Dudum.
首席執行官安德魯·杜杜姆說：“Kare的經驗爲我們提供了難以置信的豐富專業知識，因爲我們將卓越的臨床表現、醫療保健和技術等最有價值的要素彙集在一起，爲客戶重新定義了健康和保健。”
Price Action: Hims & Hers shares were up by 5.12% at $20.50 at the time of writing, according to Benzinga Pro.
價格走勢：根據Benzinga Pro的數據，在撰寫本文時，Hims & Hers的股價上漲了5.12％，至20.50美元。
- Biden's Exit From Presidential Race 'Yet Another Curveball For Equity Investors': Analysts
- 拜登退出總統競選 “股票投資者的又一曲線”：分析師
Image: Courtesy of Hims & Hers Health, Inc.
圖片：由 Hims & Hers Health, Inc. 提供